Terumo completes acquisition of University of Oxford spinout OrganOx for a record $1.5bn

Published on October 31, 2025

OrganOx, a pioneering Oxford University spinout transforming kidney and liver transplantation, has been fully acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion, marking the largest exit in Oxford University’s spinout portfolio to date and the first in excess of £1bn. The agreement for the acquisition was announced in August 2025.
Continue reading on website
Other news

Expert Comment: How to build a ghost

October 31, 2025
Halloween merchandise is worth around $10 billion per annum in America alone. Ghosts, witches, and zombies are obviously products of a uniquely human imagination – but why? Harvey Whitehouse, Professor of Social Anthropology in the Institute of Social and Cultural Anthropology, University of Oxford, writes that the answer lies in the way the human brain develops.

Scientists recreate cosmic ‘fireballs’ to probe mystery of missing gamma rays

November 3, 2025
An international team of scientists, led by the University of Oxford, has achieved a world-first by creating plasma 'fireballs' using the Super Proton Synchrotron accelerator at CERN, Geneva, to study the stability of plasma jets emanating from blazars. The results, published in PNAS, could shed new light on a long-standing mystery about the Universe’s hidden magnetic fields and missing gamma rays